Anti-HSV-1 agents: an update
Herpes simplex virus type I (HSV-1) is a member of the α-herpesvirus subfamily and is capable of causing herpes simplex keratitis, herpes labialis, and herpes simplex encephalitis. HSV-1 is well known for its lytic infections at the primary sites and for establishing latency in the sensory neuronal...
Saved in:
| Main Authors: | Wenwen Lv, Lei Zhou, Jia Wu, Jishuai Cheng, Yongzhong Duan, Wen Qian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1451083/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interest and Expectations for a Herpes Vaccine Among People Diagnosed with Genital HSV 1-2 Infection: Results from an Italian Survey
by: Lovel Lisac, et al.
Published: (2024-11-01) -
A drug repurposing screen identifies decitabine as an HSV-1 antiviral
by: Laura Bautista, et al.
Published: (2024-11-01) -
Serotype-specific host proteome remodeling in human foreskin fibroblasts during lytic HSV-1 and HSV-2 infection
by: Xiaohong Pan, et al.
Published: (2025-07-01) -
Case report: HSV lymphadenitis in immunocompromised patient with CLL
by: Talal Al-Assil, et al.
Published: (2024-12-01) -
Identifying the Multifactorial Triggers of Monthly Recurrent HSV-1 Reactivation: A Case Report
by: Fetriani U, et al.
Published: (2025-07-01)